• Trendlyne logo
  • Markets
  • Alerts
  • F&O
  • MF
  • Reports
  • Screeners
  • Subscribe
  • Superstars
  • Portfolio
  • Watchlist
  • Insider Trades
  • Results
  • Data Downloader
  • Events Calendar
  • What's New
  • Explore
  • FAQs
  • Widgets
More
    Search stocks
    IND USA
    IND
    IND
    IND
    USA
    • Stocks
    • Futures & Options
    • Mutual Funds
    • News
    • Fundamentals
    • Reports
    • Corporate Actions
    • Alerts
    • Shareholding
    logo
    Pfizer Ltd.
    13 Aug 2025
    5023.50
    -0.85%
    Pfizer Q1 Results: Net Profit Climbs 27%, Margins Expand
    Pfizer Q1 Results: Net Profit Climbs 27%, Margins Expand
    NDTV Profit
    The drugmaker's bottom-line soared to Rs 191.75 crore during the April-June period, compared to Rs 150.71 crore for the same period last year.
    Copy LinkShare onShare on Share on Share on
    Pfizer Ltd. is trading below its 30 day SMA of 5249.8
    logo
    Alkem Laboratories Ltd.
    12 Aug 2025
    Analyst Buy
    5539.50
    0.81%
    Alkem to accelerate its non-US business as part of long-term growth plans: CEO
    Business Line
    Plans to set up a subsidiary in Saudi Arabia
    Copy LinkShare onShare on Share on Share on
    ICICI Securities Limited increased Buy price target of Alkem Laboratories Ltd. to 6400.0 on 19 Sep, 2025.
    Alkem Labs Q1 profit rises 22% to 664 cr on India, overseas sales growth
    Business Standard | 12 Aug 2025
    logo
    Granules India Ltd.
    12 Aug 2025
    523.15
    -0.60%
    Granules India's Q1 FY26 net profit down 1% at 112 cr
    Business Line
    The total revenue of the Hyderabad-based company increased 3 percent at 1210 crore in the quarter under review as against 1179 crore in the year-ago period
    Copy LinkShare onShare on Share on Share on
    Granules India Ltd. is trading above all available SMAs
    logo
    Natco Pharma Ltd.
    12 Aug 2025
    855.30
    -1.06%
    Natco Pharma's Q1 FY26 net down 28% at 480 crore
    Business Line
    The total revenue of the Hyderabad based company too declined at 1390 crore as against 1410crore in the year -ago period
    Copy LinkShare onShare on Share on Share on
    Geojit BNP Paribas decreased Hold price target of Natco Pharma Ltd. to 940.0 on 17 Sep, 2025.
    logo
    Lupin Ltd.
    12 Aug 2025
    US FDA Observation
    2006.70
    0.11%
    Lupin partners with Sandoz to commercialise ranibizumab in different markets
    Business Line
    Sandoz will oversee commercialisation of the product, while Lupin will be responsible for manufacturing and regulatory submissions
    Copy LinkShare onShare on Share on Share on
    Lupin Ltd. is trading below its 200 day SMA of 2025.5
    logo
    Pfizer Ltd.
    12 Aug 2025
    5023.50
    -0.85%
    Pfizer share price up 3% on rolling out this vaccine; key details inside
    Business Standard
    Pfizer's share price gained today after the company announced the launch of its next-generation 20-valent pneumococcal conjugate vaccine (PCV20) for adults in India.
    Copy LinkShare onShare on Share on Share on
    Pfizer Ltd. is trading below its 30 day SMA of 5249.8
    Pfizer Launches Next-Gen Vaccine For Pneumococcal Disease
    NDTV Profit | 11 Aug 2025
    logo
    Wockhardt Ltd.
    12 Aug 2025
    1476.60
    -0.30%
    Wockhardt Eyes Healthy Bottom Line' In Coming Quarters Amid US Tariff Concerns
    Wockhardt Eyes Healthy Bottom Line' In Coming Quarters Amid US Tariff Concerns
    NDTV Profit
    The company recently announced its exit from the loss-making US generics business.
    Copy LinkShare onShare on Share on Share on
    Wockhardt Ltd. is trading above its 200 day SMA of 1469.8
    logo
    Sai Life Science Ltd.
    11 Aug 2025
    893.40
    2.18%
    Sai Life Sciences shares surge 11% in 2 days on strong Q1 earnings
    Business Standard
    The rally in the share price of Sai Life Sciences comes after the company swung back to report a profit of 60 crore in Q1FY26
    Copy LinkShare onShare on Share on Share on
    Mutual Funds have increased holdings from 11.54% to 18.73% in Jun 2025 qtr.
    logo
    Biocon Ltd.
    11 Aug 2025
    359.20
    -0.81%
    Biocon shares slip 3% as Q1 results miss estimates; should you sell?
    Business Standard
    Biocon shares fell 3 per cent after it reported a 95.2 per cent decline in net profit in Q1FY26
    Copy LinkShare onShare on Share on Share on
    Number of FII/FPI investors increased from 305 to 333 in Jun 2025 qtr.
    logo
    Mankind Pharma Ltd.
    09 Aug 2025
    2561.20
    -1.30%
    Mankind Pharma Confident GLP-1 Won't Dent Anti-Diabetic Portfolio Growth
    Mankind Pharma Confident GLP-1 Won't Dent Anti-Diabetic Portfolio Growth
    NDTV Profit
    Even if shifts occur within the anti-diabetes segment, such as therapies moving from the top to the bottom of the market pyramid, Mankind expects to remain stable.
    Copy LinkShare onShare on Share on Share on
    Mankind Pharma Ltd. is trading below its 50 day SMA of 2567.5
    more
    loading
    Trendlyne Logo Trendlyne
    Stay ahead of the market
    Markets Today
    • Nifty 50 today
    • Sensex today
    • Latest Quarterly results
    • FII & DII data today
    Dashboard
    • Industry & Sector analysis
    • ETFs
    • Mutual Funds
    • Bullish & Bearish spread
    • Global Indices
    Tools
    • Compare stocks
    • Widgets
    • Data Downloader
    • Excel Connect
    IPOs
    • Dashboard (Mainboard & SME)
    • Upcoming IPOs
    • Recently Listed IPOs
    • Most Successful IPOs
    Upcoming IPOs
    • GK Energy
    • Siddhi Cotspin
    • Saatvik Green Energy
    Quick Links
    • Contact us
    • Blogs
    • FAQs
    Company
    • Privacy
    • Terms of Use
    • Disclaimer
    Trendlyne Products
    • Starfolio
    • SmartOptions
    • Trendlyne US Global
    Get Mobile App
    • Android
    • iOS

    Copyright © 2025 Giskard Datatech Pvt Ltd